Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsJeff Meacham has spoken on 1 earnings call across 1 company, most recently for Merck & Co., Inc. on February 3, 2026. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer) and 7 others.
“So you're about to hit two years on the market. Can you guys speak to trends on duration of therapy or maybe real-world safety tolerability, and if anything, is different versus phase three?”
Transcript header (unverified)
Drug Manufacturers - General · Healthcare
